IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 16, 2003
July 21, 2021
8363a117-564d-4f47-9897-7aea13a1ef9f
Related Documents
Validation of Procedures for Processing of Human Tissues Intended for Transplantation: Guidance for Industry
Guidance DocumentMarch 8, 2002Center for Biologics Evaluation and Research
Determining Donor Eligibility for Autologous Donors of Blood and Blood Components Intended Solely for Autologous Use - Compliance Policy: Guidance for Industry
Guidance DocumentAugust 1, 2016Center for Biologics Evaluation and Research
Biological Product Deviation Reporting for Blood and Plasma Establishments: Guidance for Industry
Guidance DocumentMarch 12, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox